APOLLO HOSPITALS ENTER. L vs LINCOLN PHARMA LTD
A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and LINCOLN PHARMA LTD (LINCOLN) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs LINCOLN on 8 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation13
- Profitability21
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
LINCOLN takes 3/4How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
APOLLOHOSP takes 2/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
APOLLOHOSP takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
APOLLOHOSP takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
- − ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
- + ["Company is almost debt free."]
- − ["The company has delivered a poor sales growth of 9.61% over past five years.", "Company has a low return on equity of 13.8% over last 3 years.", "Earnings include an other income of Rs.42.4 Cr.", "Dividend payout has been low at 4.11% of profits over last 3 years", "Working capital days have increased from 159 days to 239 days"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.